Reshma Kewalramani M.D.
As CEO of Vertex Pharmaceuticals, Dr. Reshma Kewalramani is no newcomer to the field of medicine. Prior to Vertex, she worked at Amgen for over twelve years, three of which she served as vice president. Her passion for helping patients and her commitment to R&D has led the team at Vertex to develop remarkable advances in medicine for treating debilitating diseases such as cystic fibrosis (CF), alpha-1 antitrypsin deficiency, APOL1-mediated kidney diseases, sickle cell disease, and beta- thalassemia. She has been named to Business Insider’s list of 10 people transforming health care, the PharmaVOICE 100 list of the most inspiring and influential leaders in the life sciences, and Boston Business Journal’s list of Women Who Mean Business. Reshma received her medical degree from the Boston University School of Medicine and completed a General Management Program at Harvard University,
Year appointed: 2020